Community study of fixed-combination adapalene 0.1% and benzoyl peroxide 2.5% in acne

SKINmed

Volumn 8, Issue 1, 2010, Pages 17-22

  Troielli, Patricia A ^a   Asis, Beatriz ^a   Bermejo, Alcira ^a   Bittar, Mario ^a   Cabrera, Hugo ^a   Castro, Carla ^a   Chouela, Ezequiel ^a   Cordero, Andrés ^a   Dobrinin, Roberto ^a   Escobar, Sergio ^a   Fortino, Mirta ^a   Galimberti, Daniel ^a   Galimberti, Gaston ^a   Giovo, Maria Elsa ^a   Gomez, Beatriz ^a   Gras, Maria del Carmen ^a   Ibarra, Mónica ^a   Kizlansky, Viviana ^a   Chabbert, Patricio Martinez ^a   Ramonda, Sergio ^a  

^a The Argentina Epiduo Study Group   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; BENZOYL PEROXIDE; NAPHTHALENE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; DRUG COMBINATION; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PATIENT SATISFACTION; TREATMENT OUTCOME;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOYL PEROXIDE; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; NAPHTHALENES; PATIENT SATISFACTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77957673541     PISSN: 15409740     EISSN: 17517125     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Balkrishnan R, Kulkarni AS, Cayce K, Feldman SR. Predictors of healthcare outcomes and costs related to medication use in patients with acne in the United States. Cutis. 2006;77:251-255.
2. Williams C, Layton AM. Persistent acne in women: implications for the patient and for therapy. Am J Clin Dermatol. 2006;7:281-290.
3. Kaminsky A. Consenso sobre Acne. Sociedad Argentina de Dermatologia. 2005. http://www.sad.org.ar/revista/pdf/acne.pdf. Accessed April 19, 2009.
4. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49:S1-S37.
5. Thiboutot D, Gollnick H, Bettoli V, et al. New insights in the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5 suppl):S1-S50.
6. Del Rosso JQ, Leyden JJ. Status report on antibiotic resistance: implications for the dermatologist. Dermatol Clin. 2007;25:127-132.
7. Dreno B, Bettoli V, Ochsendorf F, et al. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations. Eur J Dermatol. 2006;16:565-571.
8. Czernielewski J, Michel S, Bouclier M, Baker M, Hensby JC. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne. J Eur Acad Dermatol Venereol. 2001;15 suppl 3:5-12.
9. Cunliffe WJ, Meynadier J, Alirezai M, et al. Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle. J Am Acad Dermatol. 2003;49:S218-S226.
10. Wolf JE, Jr, Kaplan D, Kraus SJ, et al. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study. J Am Acad Dermatol. 2003;49:S211-S217.
11. Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Arsonnaud S, Kang S. Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study. Skinmed. 2005;4:138-146.
12. Mills OH, Jr, Kligman AM, Pochi P, Comite H. Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol. 1986;25:664-667.
13. Tanghetti E, Kircik L, Wilson D, Dhawan S. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne. J Drugs Dermatol. 2008;7:534-538.
14. McKeage K, Keating GM. Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne. Am J Clin Dermatol. 2008;9:193-204.
15. Kircik L. Community-based trial results of combination clindamycin 1%-benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne. Cutis. 2007;80:10-14.
16. Pariser DM, Westmoreland P, Morris A, Gold MH, Liu Y, Graeber M. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6:899-905.
17. Thiboutot DM, Weiss J, Bucko A, et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol. 2007;57:791-799.
18. Stein-Gold LS, Tan J, Werschler W. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. Cutis. 2009;84:110-116.
19. Loesche C, Pernin C, Poncet M. Adapalene 0.1% and benzoyl peroxide 2.5% as a fixed-dose combination gel is as well tolerated as the individual components alone in terms of cumulative irritancy. Eur J Dermatol. 2008;18:524-526.
20. Andres P, Pernin C, Poncet M. Adapalene-benzoyl peroxide oncedaily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants. Cutis. 2008;81:278-284.
21. Tenaud I, Khammari A, Dreno B. In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions. Exp Dermatol. 2007;16:500-506.
22. Eichenfield LF, Nighland M, Rossi AB, et al. Phase 4 study to assess tretinoin pump for the treatment of facial acne. J Drugs Dermatol. 2008;7:1129-1136.
23. Weiss J, Shavin J, Davis MW. Overall results of the BEST study following treatment of patients with mild to moderate acne. Cutis. 2003;71:10-17.
24. Fernandez-Obregon A, Davis MW. The BEST study: evaluating efficacy by selected demographic subsets. Cutis. 2003;71:18-26.